Seizert Capital Partners LLC Has $37.41 Million Position in The Cigna Group (NYSE:CI)

Seizert Capital Partners LLC grew its holdings in The Cigna Group (NYSE:CI - Free Report) by 7.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 135,467 shares of the health services provider's stock after purchasing an additional 9,938 shares during the period. The Cigna Group comprises 1.7% of Seizert Capital Partners LLC's portfolio, making the stock its 29th largest holding. Seizert Capital Partners LLC's holdings in The Cigna Group were worth $37,408,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group in the third quarter valued at $37,000. Collier Financial bought a new stake in The Cigna Group in the 4th quarter valued at approximately $32,000. ORG Wealth Partners LLC acquired a new position in shares of The Cigna Group during the 4th quarter worth approximately $34,000. Harbor Capital Advisors Inc. acquired a new position in shares of The Cigna Group during the 3rd quarter worth approximately $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group during the 4th quarter worth approximately $37,000. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Price Performance

NYSE:CI traded up $0.98 during trading hours on Wednesday, hitting $309.84. 1,313,699 shares of the stock were exchanged, compared to its average volume of 1,843,769. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The firm's fifty day moving average price is $291.31 and its 200 day moving average price is $318.05. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The company has a market cap of $86.18 billion, a P/E ratio of 25.31, a P/E/G ratio of 0.98 and a beta of 0.54.

The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period last year, the firm earned $6.79 EPS. As a group, equities research analysts anticipate that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.95%. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's dividend payout ratio is currently 49.35%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CI. Sanford C. Bernstein downgraded The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price objective for the company. in a research report on Thursday, February 6th. Piper Sandler reissued an "overweight" rating and issued a $348.00 price target (down previously from $394.00) on shares of The Cigna Group in a research note on Monday, February 3rd. Cantor Fitzgerald decreased their target price on The Cigna Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Oppenheimer cut their price target on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a report on Friday, January 31st. Finally, Stephens dropped their target price on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $372.31.

Insider Activity at The Cigna Group

In other news, insider Nicole S. Jones sold 4,904 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the completion of the sale, the insider now owns 29,421 shares in the company, valued at approximately $9,065,198.52. This represents a 14.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by corporate insiders.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.